May 8, 2026

The New Executive Order: Implications for Psychedelic Treatment

Sandy Newes
Category: Podcasts
No comments
Gina Giorgio

Gina Giorgio is the Director of Strategy and Development at Students for Sensible Drug Policy (SSDP), the largest youth-led network working to end the War on Drugs through evidence-based, compassionate, and human rights-aligned policies. In her role, she helps lead federal and state efforts in psychedelic and cannabis policy reform, promotes drug education, and creates career-building opportunities for young people interested in advocacy. Gina is also the Founder of Carolinas for Care, which expands access to psychedelic medicines for veterans and others disproportionately impacted by trauma.

Here’s a glimpse of what you’ll learn: 

  • [3:58] Gina Giorgio shares how her early interest in mental health and her veteran family background shaped her advocacy work
  • [7:30] How media narratives and public figures have helped shift psychedelic policy conversations
  • [10:35] Psychedelic treatment access as a bipartisan mental health issue
  • [12:46] Gina’s perspective on the medical potential of psychedelics beyond recreational stereotypes
  • [14:50] How veteran suicide, PTSD, and traumatic brain injuries have fueled momentum for psychedelic reform
  • [21:26] What the recent executive order means for psychedelic research and access
  • [25:18] Why right-to-try pathways may be critical for patients with life-threatening conditions
  • [35:05] North Carolina’s Heal Act and the importance of state-level psychedelic advocacy
  • [38:14] The difference between psychedelic-assisted therapy and regulated psychedelic access
  • [47:41] Gina’s concerns about psychedelic training gaps and clinician preparedness

In this episode…

Psychedelic medicine is moving into serious conversations about research, policy, and clinical care. As access expands, how can states, clinicians, and advocates prepare responsibly while prioritizing safety, training, and equity?

Gina Giorgio’s answer is to build the infrastructure before approval arrives. As a psychedelic policy and advocacy expert, she emphasizes the need for relationship-based advocacy, state-level engagement, and thoughtful implementation. Gina recommends contacting legislators and tracking funding opportunities as policy continues to evolve. Central to her guidance, she also emphasizes preparing clinicians through better training pathways, prioritizing insurance and Medicaid coverage, and ensuring therapists and medical professionals help shape regulations rather than reacting to them later. The path forward requires both urgency and care.

In this episode of Living Medicine, Dr. Sandy Newes sits down with Gina Giorgio, Director of Strategy and Development at Students for Sensible Drug Policy (SSDP) and Founder of Carolinas for Care, to discuss psychedelic policy reform. Gina shares how veteran mental health shaped her advocacy, what the recent executive order means for psychedelic treatment access, and the importance of clinician training and state-level action.

Resources mentioned in this episode:

Quotable Moments:

  • “I was interested in how people’s… psychological experience shapes their decisions and the world around them.”
  • “I think that fueled a lot of this. But also the veteran suicide epidemic.”
  • “I think it takes that collective applied pressure to really move something like this.”
  • “I think we have a much higher likelihood of success if the people who are actually trained and experienced… are involved in that decision-making process.”
  • “We’re not just talking about like a one-time treatment, but to me, we’re really changing the culture.”

Action Steps:

  1. Engage in state-level advocacy: Reach out to your representatives and senators to share why responsible psychedelic policy matters. Repeated educational touchpoints can help motivate policymakers to act.
  2. Track federal and state funding opportunities: Regularly check ARPA-H and state legislative updates for research funding related to psychedelics, MDMA, psilocybin, and ibogaine. These opportunities can help clinics, researchers, and advocates prepare before broader approval arrives.
  3. Prioritize clinician training and preparedness: Clinicians interested in psychedelic-assisted care should seek training, build relationships with medical professionals, and stay informed about changing regulations. Without better training pathways, there may be a shortage of providers ready to work safely with these medicines.
  4. Advocate for insurance and Medicaid coverage: Support efforts that make psychedelic treatments accessible beyond private-pay models. Without coverage, long treatment sessions, medical oversight, and facility costs could prevent many people from receiving care.
  5. Build community and integration support: Create or participate in peer support, integration groups, and trauma-informed care networks after psychedelic treatment. The weeks after treatment can be a sensitive window, making ongoing support essential for long-term healing.

Sponsor for this episode…

This episode is brought to you by the Living Medicine Institute.

LMI is a training, resource, and membership program educating providers about the legal and safe use of psychedelic-assisted psychotherapy.

To learn more or participate, visit https://livingmedicineinstitute.com

Join the Newsletter!

Sign up for our newsletter and get free resources to your inbox.

Tags

The Living Medicine Institute turns regular providers into psychedelic providers, with an emphasis on ethics, scope of practice, and a commitment to ongoing learning.

Contact

Living Medicine Institute
218 Chestnut Street
Asheville, NC 28801
Email Us

Resources

© 2025 Living Medicine Institute. All Rights Reserved. Designed and Developed by Troop-Creative & Digital Strategy Works
Living Medicine Institute
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.